Histone Deacetylase Inhibitors Market, by Drug (Zolinza (Vorinostat), Istodax (Romidepsin), Beleodaq (Belinostat), Farydak (Panabinostat) and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

  • To Be Published : Aug 2019 |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Histone deacetylases (HDACs), also called as lysine deacetylases, are enzymes that remove acetyl group from the lysine (amino acid) present on histones. This ensures wrapping up of histones on the DNA more tightly and suppresses the gene effect. Histone acetyltransferase (HAT) works exactly opposite to the histone deacetylases and is related to gene transcription. Thus, DNA expression is regulated by acetylation and de-acetylation. Aberrations and mutations induced into HDACs are known to develop cancers and some other chronic conditions including cardiovascular diseases, neurodegenerative diseases, inflammatory diseases, osteoporosis, etc. Histone deacetylases inhibitors are agents that inhibit the activity of HDAC (deacetylation) and instigate apoptosis of tumor cells. In humans, there are around 18 HDACs, which are categorized into four classes - HDAC I, II (A and B), III and IV.

Global Histone Deacetylase Inhibitors Market Drivers

Research and development activities related to HDACs are expected to propel the global histone deacetylase inhibitors market growth. For instance, in May 2018, EddingPharm Oncology Co. Ltd. and Syndax Pharmaceuticals, Inc. commenced a study on combination of exemestane and entinostat (HDAC) for the treatment of advanced breast cancer in Chinese patients. Exemestane lowers the level of estrogen (it drives the breast cancer cell growth) and entinostat is expected to enhance the anti-tumor effect of exemestane. Currently, it’s in the third phase of clinical trials and is being studied for the safety and efficacy of the combined drugs.

Furthermore, in June 2016, The Netherlands Cancer Institute commenced a clinical trial study of vorinostat, a drug for the treatment of skin neoplasms. It is being studied for the safety and efficacy, and around 22 participants are involved in it. Currently, it is in the second phase of clinical trial. Such research activities are expected to accelerate the global histone deacetylase inhibitors market growth.

Approvals of the drugs related to histone deacetylases from regulatory bodies are expected to boost the global histone deacetylase inhibitors market growth. For instance, in February 2015, Novartis AG received approval for Farydak from U.S. Food & Drug Administration (FDA). It is being used for the treatment of patients with multiple myeloma. It is approved for the treatment in combination with bortezomib and dexamethasone. Farydak is the first HDAC inhibitor to receive an approval for the treatment of multiple myeloma. These factors are expected to propel the global histone deacetylase market growth.

Global Histone Deacetylase Inhibitors Market Regional Analysis

North America is expected to hold a dominant position in the global histone deacetylase inhibitors market, over the forecast period. Factors such as increasing prevalence of cancer patients is expected to drive the North America’s histone deacetylase inhibitors market growth. For instance, according to National Institutes of Health (NIH), around 439.2 (per 100,000 men and women) cases of cancer were found in a time span of 2011–2015, in the U.S. This may indicate a higher adoption for HDAC inhibitors and thereby, is expected to impact positively on the global histone deacetylase inhibitors market growth.

Global Histone Deacetylase Inhibitors Market Restraints

Side effects associated with the inhibitors of HDAC may hamper the global histone deacetylase inhibitors market growth. Farydak can have side effects such as severe diarrhea, fatal cardiac events, and arrhythmia while Zolinza can cause swelling on face, lip, etc., clotting of blood in legs or lungs, and sometimes difficulty in breathing. These side effects may obstruct the global histone deacetylase inhibitors market growth.

Global Histone Deacetylase Inhibitors Market Key Players

Some of the major players operating in the global histone deacetylase inhibitors market include, Novartis AG, Merck & Co. Inc., Celgene Corp., Acrotech Biopharma LLC, and AbbVie Inc.

Global Histone Deacetylase Inhibitors Market Taxonomy

The global histone deacetylase inhibitors market is segmented on the basis of drug, distribution channel, and regions. 

By Drug

  • Zolinza (Vorinostat)
  • Istodax (Romidepsin)
  • Beleodaq (Belinostat)
  • Farydak (Panabinostat)
  • Others

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.